Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The American Journal of Gastroenterology|April 27, 2011
Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled studyNimish B Vakil, F Jacob Huff, Amy Bian, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 12, 2017
Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insuranceLisa Meng, Amy Bian, Scott Jordan, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2016
A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosisJeremy M Shefner, Andrew A Wolff, Lisa Meng, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 21, 2017
Longitudinal modeling to predict vital capacity in amyotrophic lateral sclerosisSamad Jahandideh, Albert A Taylor, Danielle Beaulieu, et al.
Annals of Clinical and Translational Neurology|April 25, 2018
Improved stratification of ALS clinical trials using predicted survivalJames D Berry, Albert A Taylor, Danielle Beaulieu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 7, 2018
VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristicsJinsy A Andrews, Merit E Cudkowicz, Orla Hardiman, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 1, 2021
Noninvasive ventilation use by patients enrolled in VITALITY-ALSStacy A Rudnicki, Jinsy A Andrews, Amy Bian, et al.
Pageof 1